Form 4 holding
EVP, Chief Development Officer
HERON THERAPEUTICS, INC. /DE/
- Security class
- Restricted Stock Units
- Shares / value
- 12,500
- Estimated value
- $493,970
- Report date
- 06 Jun 2026
- Price
- $2.64
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount